000 | 01504 a2200397 4500 | ||
---|---|---|---|
005 | 20250511153953.0 | ||
264 | 0 | _c19770718 | |
008 | 197707s 0 0 eng d | ||
022 | _a0023-6837 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVelosa, J A | |
245 | 0 | 0 |
_aExperimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss. _h[electronic resource] |
260 |
_bLaboratory investigation; a journal of technical methods and pathology _cMay 1977 |
||
300 |
_a527-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aFactor VIII _xmetabolism |
650 | 0 | 4 |
_aFibrin _xmetabolism |
650 | 0 | 4 |
_aGlomerulonephritis _xphysiopathology |
650 | 0 | 4 |
_aGlomerulosclerosis, Focal Segmental _xchemically induced |
650 | 0 | 4 |
_aImmunoglobulin G _xmetabolism |
650 | 0 | 4 |
_aImmunoglobulin M _xmetabolism |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 |
_aKidney Glomerulus _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aProteinuria _xchemically induced |
650 | 0 | 4 |
_aPuromycin Aminonucleoside _xadverse effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSialoglycoproteins _xmetabolism |
700 | 1 | _aGlasser, R J | |
700 | 1 | _aNevins, T E | |
700 | 1 | _aMichael, A F | |
773 | 0 |
_tLaboratory investigation; a journal of technical methods and pathology _gvol. 36 _gno. 5 _gp. 527-34 |
|
999 |
_c872644 _d872644 |